P/B
8,5
SOPHiA Genetics SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
$710M
Market Cap • 9/25/2026
2011
(15 years)
Founded
2021
(5 years ago)
IPO
NASDAQ
Listing Exchange
Switzerland
Country
Valuation
P/S
8,2
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
1,2
EPS
—
Market Cap
Market Cap
710M
EV
664,1M
EV/Revenue
7,7
EV/EBITDA
-10,5
EV/EBIT
-9
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-10,2%
Total Yield
-10,2%
Payout
0%
Retained Earnings
-561M
Profitability
Gross Margin
66,6%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
40,4%
Capex/Revenue
1,7%
Capex/D&A
14%
Capex/OCF
-3,7%
SBC/OCF
—
% PPE
8%
% Goodwill
0%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
20,3%
CAGR Op. Income 5Y
7,8%
CAGR Net Income 5Y
9,2%
CAGR EPS 5Y
6,2%
CAGR OCF 5Y
-7,4%
Leverage
N.D./EBITDA
0,7
Debt/Equity
0%
Current Ratio
2,7
Quick Ratio
2,1
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!